This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hocquet, D.
Right arrow Articles by Plésiat, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hocquet, D.
Right arrow Articles by Plésiat, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2007, p. 3531-3536, Vol. 51, No. 10
0066-4804/07/$08.00+0     doi:10.1128/AAC.00503-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Pseudomonas aeruginosa May Accumulate Drug Resistance Mechanisms without Losing Its Ability To Cause Bloodstream Infections{triangledown}

Didier Hocquet,1* Philippe Berthelot,2 Micheline Roussel-Delvallez,3 Roger Favre,4 Katy Jeannot,1 Odile Bajolet,5 Nicole Marty,6 Florence Grattard,2 Patricia Mariani-Kurkdjian,7 Edouard Bingen,7 Marie-Odile Husson,3 Gérard Couetdic,1 and Patrick Plésiat1

Centre National de Référence Résistance aux Antibiotiques: Pseudomonas aeruginosa, Hôpital Jean Minjoz, Besançon,1 Laboratoire de Bactériologie-Virologie, Hôpital Nord, Saint Etienne,2 Laboratoire de Bactériologie, Hôpital Calmette, Lille,3 Laboratoire de Microbiologie Clinique, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,4 Laboratoire de Bactériologie-Hygiène, Hôpital Robert Debré, Reims,5 Laboratoire de Bactériologie-Hygiène, Hôpital Rangueil, Toulouse,6 Laboratoire de Microbiologie, Hôpital Robert Debré, Paris, France7

Received 13 April 2007/ Returned for modification 4 May 2007/ Accepted 25 July 2007

In this study, we systematically investigated the resistance mechanisms to ß-lactams, aminoglycosides, and fluoroquinolones of 120 bacteremic strains of Pseudomonas aeruginosa. Pulsed-field gel electrophoresis genotyping showed that 97 of these strains were represented by a single isolate, 10 by 2 and 1 by 3 clonally related isolates, respectively. Seventy-five percent (90 out of 120) of the bacteremic P. aeruginosa strains displayed a significant resistance to one or more of the tested antimicrobials (up to 11 for 1 strain). These strains were found to harbor a great diversity of resistance mechanisms (up to 7 in 1 strain), leading to various levels of drug resistance. Interestingly, 11 and 36% of the isolates appeared to overproduce the MexAB-OprM and MexXY-OprM efflux systems, respectively. Altogether, our results show that P. aeruginosa may accumulate intrinsic (overproduction of cephalosporinase AmpC, increased drug efflux, fluoroquinolone target mutations, and deficient production of porin OprD) and exogenous (production of secondary ß-lactamases and aminoglycoside-modifying enzymes) resistance mechanisms without losing its ability to generate severe bloodstream infections. Consequently, clinicians should be aware that multidrug-resistant P. aeruginosa may remain fully pathogenic.

* Corresponding author. Mailing address: Centre National de Référence Résistance aux antibiotiques: Pseudomonas aeruginosa, Hôpital Jean Minjoz, 25030 Besançon, Cedex, France. Phone: (33) 3 81 66 82 86. Fax: (33) 3 81 66 89 14. E-mail: dhocquet{at}chu-besancon.fr

{triangledown} Published ahead of print on 6 August 2007.

Antimicrobial Agents and Chemotherapy, October 2007, p. 3531-3536, Vol. 51, No. 10
0066-4804/07/$08.00+0     doi:10.1128/AAC.00503-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Viedma, E., Juan, C., Acosta, J., Zamorano, L., Otero, J. R., Sanz, F., Chaves, F., Oliver, A. (2009). Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum {beta}-Lactamases GES-1 and GES-5 in Spain. Antimicrob. Agents Chemother. 53: 4930-4933 [Abstract] [Full Text]  
  • Vettoretti, L., Plesiat, P., Muller, C., El Garch, F., Phan, G., Attree, I., Ducruix, A., Llanes, C. (2009). Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients. Antimicrob. Agents Chemother. 53: 1987-1997 [Abstract] [Full Text]  
  • Moya, B., Juan, C., Alberti, S., Perez, J. L., Oliver, A. (2008). Benefit of Having Multiple ampD Genes for Acquiring {beta}-Lactam Resistance without Losing Fitness and Virulence in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52: 3694-3700 [Abstract] [Full Text]  
  • Jeannot, K., Elsen, S., Kohler, T., Attree, I., van Delden, C., Plesiat, P. (2008). Resistance and Virulence of Pseudomonas aeruginosa Clinical Strains Overproducing the MexCD-OprJ Efflux Pump. Antimicrob. Agents Chemother. 52: 2455-2462 [Abstract] [Full Text]  
  • Hocquet, D., Muller, A., Blanc, K., Plesiat, P., Talon, D., Monnet, D. L., Bertrand, X. (2008). Relationship between Antibiotic Use and Incidence of MexXY-OprM Overproducers among Clinical Isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52: 1173-1175 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»